About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Second-Line Treatment Landscape for Advanced HCC
Second-Line Treatment Landscape for Advanced HCC
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
TKI in the Management of Advanced HCC
By
Icahn School of Medicine at Mount Sinai
FEATURING
Augusto Villanueva
By
Icahn School of Medicine at Mount Sinai
FEATURING
Augusto Villanueva
223 views
July 7, 2022
0 Comments
Login to view comments.
Click here to Login
Second-Line Treatment Landscape for Advanced HCC
17:15
Lorenza Rimassa
2L Systemic Treatment Approaches for Advanced HCC
15:29
10th Annual Winship Cancer Institute Gastrointestinal Cancer Virtual Symposium
Sequencing Therapy in Hepatocellular Carcinoma: A Good Problem to Ha…
Feat.
M. Akce
13:03
CECOG Academy
Updates on Cabozantinib in RCC, HCC, and Thyroid Cancers
Feat.
B. Mrinakova
24:13
UChicago Medicine: Sixth Annual Updates in Digestive Diseases
Liver Transplantation for HCC: Role of AFP, Overview of Current &…
Feat.
A. A. Pillai
33:00
35th Annual New Treatments in Chronic Liver Disease
Systemic Therapies for HCC: What Does the Gastroenterologist Need to…
Feat.
C. Frenette,
J. Gutierrez,
C. J. Karvellas
07:19
Northwell Health
Cabozantinib in Patients With Advanced and Progressing Hepatocellula…
Feat.
A. Levy
31:02
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2022
Updates in Systemic Therapy for HCC
Feat.
R. Finn
55:46
University of Colorado Cancer Center
UColorado Updates on Hepatocellular Carcinoma and Biliary Tract Canc…
Feat.
L. Davis
09:02
ASCO 2022 Conference Coverage
ASCO 2022 Immunotherapy With Nivolumab After Progression on Lenvatin…
Feat.
A. Rauthan
05:12
ASCO 2022 Conference Coverage
ASCO 2022 IMMUNIB Trial: A Single-Arm, Phase II Study Evaluating Saf…
Feat.
A. Vogel
39
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Immunotherapy With Nivolumab After Progr…
Feat.
A. Rauthan
04:54
ASCO 2022 Conference Coverage
ASCO 2022 IMMUTACE - A Biomarker-Orientated Phase II, Single-Arm, Op…
Feat.
A. Vogel
07:35
ASCO 2022 Conference Coverage
ASCO 2022 on an Open-Label, Multicenter, Randomized Phase II Study o…
Feat.
A. Ruth He,
F. Banovac
40
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on an Open-Label, Multicenter, Randomize…
Feat.
A. Ruth He,
F. Banovac
05:07
Icahn School of Medicine at Mount Sinai
TKI in the Management of Advanced HCC
Feat.
A. Villanueva
03:33
ASCO 2022 Conference Coverage
ASCO 2022 Patient-Reported Outcomes From the Phase 3 HIMALAYA Study …
Feat.
P. Galle
10:11
ASCO 2022 Conference Coverage
ASCO 2022 on Atezolizumab + Bevacizumab vs Lenvatinib or Sorafenib i…
Feat.
M. Rimini